Skip to main content

Viagra Ingredient Shows Promise in Treating Deadly Childhood Disease

Published on June 22, 2026, 4:48 p.m.
Viagra Ingredient Shows Promise in Treating Deadly Childhood Disease

Topic: Health

Researchers found that a common drug ingredient, sildenafil, can improve symptoms of Leigh syndrome, a rare and severe childhood disorder. The study involved six patients who received continuous treatment.

Leigh Syndrome is a Rare and Devastating Childhood Disorder Leigh syndrome is a rare metabolic condition that affects the brain and muscles, usually appearing in infancy or early childhood. It's caused by defects in cellular energy production, leading to symptoms like seizures, muscle weakness, paralysis, and delayed development.

An Unexpected Use for a Well-Known Drug Researchers identified sildenafil, a PDE-5 inhibitor best known for treating erectile dysfunction, as a potential therapy. The drug is also used in infants to treat pulmonary hypertension due to its ability to widen blood vessels. In the study, six patients between 9 months and 38 years old received continuous sildenafil treatment.

Benefits Seen in Cells, Animal Models, and Patients The study found that sildenafil treatment was linked to measurable improvements in disease progression. Many patients showed stronger muscles, and some experienced improvements in neurological symptoms. Patients also recovered more quickly from metabolic crises, which can suddenly worsen the course of this disorder.

Why Rare Diseases Are Difficult to Treat Leigh syndrome affects about one in 36,000 children, making research especially challenging. The low case numbers make it difficult to conduct large clinical trials and study the disease directly.

Why It Matters

This breakthrough could lead to new hope for Indian students affected by Leigh syndrome or other rare diseases. It highlights the importance of innovative approaches in medical research and the potential for unexpected solutions.

Key Facts

  • Sildenafil, a common drug ingredient, was found to improve symptoms of Leigh syndrome, a rare and severe childhood disorder.
  • The study involved six patients who received continuous treatment with sildenafil.
  • Leigh syndrome affects about one in 36,000 children, making research challenging.

Key Terms

PDE-5 inhibitor
A type of drug that helps widen blood vessels

Implications

This breakthrough could lead to new hope for Indian students affected by Leigh syndrome or other rare diseases. It highlights the importance of innovative approaches in medical research and the potential for unexpected solutions.


Source: https://www.sciencedaily.com/releases/2026/03/260331001107.htm

Journal Reference:

  1. Annika Zink, Dao-Fu Dai, Annika Wittich, Marie-Thérèse Henke, Giulia Pedrotti, Sonja Heiduschka, Guillem Santamaria, Tancredi Massimo Pentimalli, Christian Brueser, Sofia Notopoulou, Abdul Rahim Umar, Aleksandra Zhaivoron, Laura Petersilie, Caleb Jerred, Jesper Bergmans, Louis Anton Neu, Fabian Schumacher, Jan Keller-Findeisen, Agnieszka Rybak-Wolf, Daniel Stach, Jeanette Reinshagen, Undine Haferkamp, Kim Krieg, Andrea Zaliani, Liliya Euro, Alessia Di Donfrancesco, Chiara Santanatoglia, Enrica Cappellozza, Marta Suarez Cubero, Mario Pavez-Giani, Oleh Bakumenko, David Meierhofer, Alan Foley, Susanne Morales-Gonzalez, Isabella Tolle, Diran Herebian, Daniele Bonesso, Giulia Cecchetto, Sakurako Nagumo Wong, Monica Moresco, Alessandra Maresca, Ilaria Decimo, Francesco De Sanctis, Annalisa Adamo, Merel J.W. Adjobo-Hermans, Roberto Duchi, Maria Barandalla, Marco Scaglia, Andrea Perota, Cesare Galli, Burkhard Kleuser, Lukas Cyganek, Chris Mühlhausen, Lars Schlotawa, Valeria Tiranti, Ertan Mayatepek, Ildiko Szabo, Chiara La Morgia, Thomas Klopstock, Valerio Carelli, Felix Distelmaier, Andrea Rossi, Nikolaus Rajewsky, Ghanim Ullah, Stefan Jakobs, Christine R. Rose, Spyros Petrakis, Frank Edenhofer, Werner J.H. Koopman, Pawel Lisowski, Anu Suomalainen, Dario Brunetti, Antonio del Sol, Emanuela Bottani, Ole Pless, Markus Schuelke, Alessandro Prigione. Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy. Cell, 2026; 189 (6): 1656 DOI: 10.1016/j.cell.2026.02.008

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.